Where is Merdury located?

Merdury is headquartered in Taipei, Taiwan.

Where does Merdury rank among its competitors?

Merdury ranks 141st amongst 292 active competitors, of which 21 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was LYOCONTRACT, which secured an undisclosed amount in May, 2026.

Who are the top competitors of Merdury?

Merdury's top competitors include Suanfarma, Nephron Pharmaceuticals and OneSource. Among them, LYOCONTRACT secured the most recent funding round in May, 2026.

Merdury - 2026 Company Profile & Competitors

Merdury is a public company based in Taipei (Taiwan), founded in 2019. It operates as a Provider of drugs development services. The company has 292 active competitors, including 21 funded and 19 that have exited. Its top competitors include companies like Suanfarma, Nephron Pharmaceuticals and OneSource.

Key Metrics

Founded Year

2019

Location

Taipei, Taiwan

Stage

Public

Ranked

141^st among 292 active competitors

Similar Companies

Suanfarma & 296 more

Exit Details

Public

View Merdury's full profile

Merdury got listed on Dec 23, 2022.

Click here to take a look at Merdury's IPO in detail

Merdury has not raised any funding rounds yet.

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Merdury include Suanfarma, Nephron Pharmaceuticals and OneSource. Here is the list of Top 10 competitors of Merdury, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Suanfarma 1993, Madrid (Spain), Acquired	Developer of generics, nutraceuticals, and APIs	-	ProA Capital, Hermes GPE	60/100
2nd	Nephron Pharmaceuticals 1937, Florida (Puerto Rico), Late Stage	Manufacturer of sterile pharmaceutical products and provider of contract manufacturing and 503B outsourcing services	$625M	Blackrockbkcc, PNC & 3 others	58/100
3rd	OneSource 1990, Bengaluru (India), Public	Pharmaceutical contract development and manufacturing organization offering pharmaceutical products	$155M	Erasmic Venture Fund, Tenshi Life Sciences ... & 14 others	57/100
4th	Quotient Sciences 1990, Nottingham (United Kingdom), Acquired	Developer and manufacturer of APIs as well as finished dosage forms	-	TA Associates, GHO Capital Partners & 1 others	55/100
5th	Wheeler Bio 2020, Oklahoma City (United States), Series A	Provider of drug research and analytical development services for multiple therapeutic areas	$103M	Echo, Charles River Laboratories & 14 others	53/100
6th	LSL Pharma Group 2023, Boucherville (Canada), Public	Integrated pharmaceutical company provides pharma products	-	-	47/100
7th	Aiolos Bio 2023, Boston (United States), Acquired	Biotech company focused on developing innovative therapies for respiratory diseases and immune conditions	$245M	Bain Capital Life Sciences, Atlas Venture ... & 3 others	47/100
8th	LYOCONTRACT 2007, Ilsenburg (Germany), Acquired	Provider of a pharmaceutical manufacturing site with capabilities for producing liquid and freeze-dried parenteral drugs in vials	-	Partners Group, Great Point Partners	45/100
9th	Althea Technologies 1998, San Diego (United States), Acquired	Contract-based manufacturer and distributor of clinical drugs and vaccines	$23M	Hercules Capital, Tech Coast Angels & 1 others	44/100
10th	Chemveda Life Sciences 2008, Hyderabad (India), Seed	Manufacturer of chemical substances and provider of research & development services	$2.58M	Pasidi Greenlands, BIRAC & 6 others	43/100
141st	Merdury 2019, Taipei (Taiwan), Public	Provider of drugs development services	-	-	20/100